Author

Victor Babawale

Observed name: Babawale Victor A

Institutions: Winnipeg Regional Health Authority, Federal Ministry of Health

Observed institutions: Winnipeg Regional Health Authority, Federal Ministry of Health

OpenAlex ID: A5026498147

Global adoption of 6-month drug-resistant TB regimens: Projected uptake by 2026

2024 · Aastha Gupta, Sandeep Juneja, et al. · PLoS ONE · 24

Prevalence of Adverse Drug Reactions to Second Line Anti Tuberculosis Drugs in Nigeria: A Cross-Sectional Study

2021 · Abideen Adedayo Ganiyu, Yohanna Kambai Avong, et al. · Journal of Tuberculosis Research · 6

Enhancing programmatic scale-up: Applying the consolidated framework for implementation research to evaluate decentralized drug-resistant tuberculosis services in Southern Nigeria

2025 · Ngozi Murphy-Okpala, Chinwe Eze, et al. · PLoS ONE · 3

Evaluating Treatment and Safety Outcomes of a Shorter Regimen for Drug-Resistant TB in Nigeria: An Implementation Research Study

2026 · Victor Babawale, Clement Adesigbin, et al. · Tropical Medicine and Infectious Disease

From birth canal to classroom: a comparative analysis of academic performance among pupils born through vaginal and cesarean deliveries in Ogbomoso, Oyo State, Nigeria

2026 · Olaniyan Akintunde Babatunde, Oluwaserimi Adewumi Ajetunmobi, et al. · Journal of Health Population and Nutrition

Trends in Antenatal Laboratory Parameters in Primary Health Care Facilities in Ogbomoso North Local Government Area, Oyo State, Nigeria: A Four-Year Retrospective Review

2025 · Olaniyan Akintunde Babatunde, Saliu Ajedotun Shittu, et al. · International journal of research and scientific innovation

Multi Drug Resistant Tuberculosis an Emerging Concern a Studyat Tertiary Health Center in Nigeria

2018 · Jacob Amos Dunga, Sabiu Abdu Gwalabe, et al. · EC Pulmonology and Respiratory Medicine

Works count: 7

Citation count: 33

H-index: 3

I10-index: 1